✦ LIBER ✦

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers

✍ Scribed by Christine Sadorge; Anna Ndiaye; Nathalie Beveridge; Schale Frazer; Rafaela Giemza; Nathalie Jolly; Julie Johnson; Helen Liddy; Catherine A. Cosgrove; Paola Allavena; Alberto Mantovani; Stéphane Béchet; Annick Fontaine-Thompson; George E. Griffin; Francis Dupont; Philippe J. Sansonetti; David J.M. Lewis

Book ID: 116960207
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 196 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2007.11.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of SC599, an o

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

✍ Odile Launay; Christine Sadorge; Nathalie Jolly; Béatrice Poirier; Stéphane Béch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 795 KB